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ABSTRACT  
 
The effects on haematology of 48 rabbits (24 of each sex) were studied by administering cypermethrin 
(CY) intraperitoneally. In each sex, animals were divided into four equal groups A, B, C and D. The 
animals in groups B, C and D received low (50 mg.kg
-1 b. wt.), medium (100 mg.kg
-1 b. wt.) and high (150 
mg.kg
-1 b. wt.) CY doses, respectively in mustard oil. Group A served as control and each animal received 
equivalent volume of mustard oil. The animals received five CY treatments (d 1, 8, 15, 22 and 29). Blood 
samples with anticoagulant from all animals were collected prior to experiment (day 0) and after every 
treatment for haematological studies. The total erythrocyte count (TEC), haemoglobin (Hb) concentration 
and packed cell volume (PCV) were analyzed at each experimental period and erythrocyte indices were 
calculated. During the experiment, significant increase in mean corpuscular volume (MCV) and significant 
decrease in TEC, Hb concentration and mean corpuscular Hb concentration (MCHC) were found in the 
male rabbits treated with CY especially at higher doses, while the decrease in these parameters in the 
female rabbits was non-significant at all dose levels and time periods. Thus, it was concluded that 
macrocytic hypochromic anaemia was induced in the male rabbits due to CY treatment, but not in the 
females at the dose levels administered during the study.     
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INTRODUCTION 
 
Pesticides have become omnipresent contaminants 
of our environment and have been found in water, soil, 
air and both human and animal tissues all over the 
world (Anwar, 1997). Silent Spring,  the book written 
by  Rachel Carson, facilitated the ban of the 
pesticide DDT in 1972 in the United States and foretold 
of the poisoning of the planet by man (Paull, 2007). 
Since then, many countries have devised policies to 
reduce pesticide use. However, data (1992–2003) of EU 
statistics show that consumption of pesticide did not 
decrease (Bjørling-Poulsen et al., 2008). Among the 
severe pesticide poisoning (3 million cases) and deaths 
(220,000) through out the world, about 99% are 
reported from the third world countries (Tinoco and 
Halperin, 1998). 
Major share of total pesticide usage is in the 
developing countries as compared to developed world 
(Anwar, 1997). Various classes of insecticides include 
organophosphate, organochlorine, carbamate and 
pyrethroid. Pyrethroids use has increased much for the 
last 10 years (Wolansky et al., 2006). The incidence of 
major outcomes and fatalities attributable to pyrethroids 
are considerably less than organophosphates (Sudakin, 
2006), however, their pathological effects have been 
encountered in experimental studies in different animals 
(Manna et al., 2004; Khan et al., 2009).  
If ectoparasites are not treated, consequences 
appear in the form of blood loss, reduced birth weight, 
behavioral changes such as excessive scratching and 
decreased weight gain and decreased milk production 
up to 15-25% per animal per year (Kakar and 
Kakarsulemankhel, 2009). Cypermethrin (CY), a 
pyrethroid is used commonly in Pakistan for the control 
of ectoparasites, which may have health risk to 
livestock as well as human beings.  None of the 
preparations available in the market are manufactured 
locally (Ahmad et al., 2009). Scanty information about 
the type of toxicity due to CY in animals of the region 
is available (Shah et al., 2007; Aslam et al., 2009). 
Contentious reports about the effects of CY on 
haematological parameters are available. No CY effect 
has been reported on Hb concentration in rats (Mansee, 
1998), while in sheep decreased Hb has been reported 
(Yousef et al., 1998). Similarly, significantly decreased 
TEC, Hb, PCV and MCHC with increased MCV in CY 
treated goats (Khan et al., 2009) and broilers (Sharaf et 
al., 2009) have been reported. Some workers, however, 
reported significantly increased Hb, TEC and PCV in 
mice treated with pyrethroids (Luty et al., 2001; 
Haratym-Maj, 2002). This study was tailored and 
performed to explore whether CY induces anaemia in 
rabbits or not, and, whether response of the pesticide 
under study is sex dependent or not. 
 
MATERIALS AND METHODS 
 
Experimental animals and protocol 
Forty eight apparently healthy, adult rabbits of 
almost the same age (female and  male, 50:50) were 
procured from the local market. They were kept under 
similar management conditions. The animal room 
temperature was maintained at 25-27°C throughout the Pakistan Vet. J., 2009, 29(4): 191-195. 
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study. Drinking water was available ad libitum. The 
green fodder Barseem  (Trifolium alexandrinum) was 
offered in the morning and evening. After 5 days of 
acclimatization, male and female rabbits were separated 
and assigned to the three CY treatments based on initial 
live weight. In each sex, group A served as control and 
each animal in the control group received equivalent 
volume of mustard oil. Animals in groups B, C and D 
received intraperitoneally low (50 mg.kg
-1 b. wt.), 
medium (100 mg.kg
-1 b. wt.) and high (150 mg.kg
-1 b. 
wt.) dose of CY, respectively dissolved in mustard oil 
on days 1, 8, 15, 22 and 29 of the experiment. 
 
Haematology  
Blood samples from all animals were collected 
prior to (d 0) and after every treatment on the next day. 
Blood samples were used for haematological studies 
including haemoglobin concentration, packed cell 
volume and total erythrocyte count. The cyanome- 
themoglobin method was used to estimate haemoglobin 
concentration, whereas microhaematocirt method was 
used for PCV and cell counts were manually executed 
using the improved Neubauer haemocytometer 
(Benjamin, 1978). Erythrocyte indices including mean 
corpuscular haemoglobin (MCH), mean corpuscular 
volume (MCV) and mean corpuscular haemoglobin 
concentration (MCHC) were calculated according to the 
formula described by Khan (2008). 
 
Data analysis 
The collected data were analyzed using analysis of 
variance (ANOVA) and mean values were compared on 
a personal computer using the Minitab statistical 
software package. The significance level was P<0.05. 
 
RESULTS 
  
The results of different haematological parameters 
in male and female rabbits are presented in Tables 1 
and 2, respectively. In males, TEC significantly 
(P<0.05) decreased in groups C and D as compared to 
A (control) at 2
nd week and in group C only at 4
th week. 
However, TEC significantly increased in group B at 3
rd 
week of the treatment (Table 1). Variation in TEC 
observed in treatment groups of female rabbits 
(compared to control) was non-significant at all periods 
(Table 2). A significant increase in PCV was observed 
in male group B at first week, whereas a non-significant 
difference throughout the experiment was observed in 
female rabbits. The Hb concentration was significantly 
(P<0.05) decreased at 3
rd weak as compared to control 
in all male treatment groups (Table 1), whereas it 
significantly increased in groups B and C at 2
nd week in 
females (Table 2).    
In the male rabbits, MCV increased significantly 
(P<0.05) at 1
st week in groups B and C, 2
nd week in 
groups C and D and 4
th week in all treated groups. The 
MCH also significantly increased at 1
st week in groups 
B and C and 4
th week in group C, but significantly 
decreased at 3
rd week in groups B and D in male 
rabbits. In the females, MCV and MCH of any group 
did not differ significantly from control at any period 
(Table 2).  
In the males, MCHC was significantly lower at 1
st 
week in groups B and D and 3
rd week in groups C and 
D but significantly higher at 2
nd week in groups B and 
D than control. In the females, MCHC was significantly 
lower at 1
st week in group D, but significantly higher at 
2
nd week in groups B and C than control. From the 
above results it was interpreted that macrocytic 
hypochromic anaemia was induced by CY in males, but 
not in female rabbits.  
 
DISCUSSION 
 
The results of the present study indicated that 
cypermenthrin (CY) induced macrocytic hypochromic 
anaemia in male rabbits but not in female rabbits. 
Previously, sex related difference in haematological 
response to pyrethroid treatment has been reported in 
mice. Luty et al. (2001) reported that irrespective of the 
dose, the deltamethrin and fenvalerate stimulated 
erythropoiesis and synthesis of Hb in male Swiss mice, 
while in female mice the administration of deltamethrin 
(25 mg.kg
-1 b. wt.) resulted in anaemia. In contrary to 
the findings of the present study, Haratym-Maj (2002) 
reported anaemia in female mice, but not in males at 
CY doses 5 mg.kg
-1 b. wt. He also reported that 
anaemia developed in female mice at low CY doses (5 
mg.kg
-1 b. wt.), whereas at high CY doses (25 mg.kg
-1 
b. wt.) no anaemia was observed. He alleged that 
female mice were principally susceptible to poisoning, 
particularly with low doses of pyrethroids used for long 
time. 
Although the mechanism of toxicity of pyrethroids 
has not been fully explored, various opinions have been 
put forward. CY can induce oxidative stress in blood 
cells (Kale et al., 1999) or may accrue in cell 
membranes and disturb structure of membrane 
(Michelangeli et al., 1990) which could lead to lysis of 
erythrocytes as a result their number would be low in 
circulation. Low Hb concentration could be due to 
enhanced Hb destruction or decreased Hb synthesis 
(Moss and Hathway, 1964). Increased activity of bone 
marrow or haemolysis could lead to impaired Hb 
synthesis (Barger, 2003). TEC production is regulated 
by tissue oxygenation. Tissue receive inadequate 
oxygen (O2) if there is an insufficient supply in inspired 
air, impaired O2 transport from alveoli into blood 
stream, hypoventilation, inadequate Hb to carry O2, 
decreased arterial O2 saturation, abnormal blood flow or 
failure of haemoglobin to release bound O2 at tissue 
sites (Helms et al., 2006). Pakistan Vet. J., 2009, 29(4): 191-195. 
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Table 1: Haemogram of male rabbits treated at various intervals with cypermethrin 
Groups (Cypermethrin doses; mg.kg
-1 b. wt.)  Parameters/ 
experimental weeks              A (0)       B (50)  C (100)  D (150) 
Total erythrocyte counts (10
6/ml) 
0     4.12 ± 0.55    4.54 ± 0.72    3.66 ± 0.72  4.52 ± 0.52 
1     4.56 ± 0.44    4.12 ± 0.42    4.30 ± 0.30  4.90 ± 0.79 
2     5.65 ± 1.20    5.08 ± 0.66      4.00 ± 0.29*    3.93 ± 0.59* 
3     4.16 ± 0.11      4.58 ± 0.19*    4.16 ± 0.10  4.46 ± 0.30 
4     5.20 ± 0.90     4.70 ± 0.32      3.88 ± 0.53*  4.62 ± 0.62 
5     5.03 ± 0.94     4.74 ± 0.21    4.97 ± 0.13  5.68 ± 1.29 
Packed cell volume (%) 
0  42.30 ± 1.08  42.40 ± 4.72  38.40 ± 1.86  42.00 ± 30.41 
1  37.00 ± 1.41    41.00 ± 3.23*  39.20 ± 1.72       39.58 ± 2.15 
2  43.50 ± 1.66  40.60 ± 1.50  43.00 ± 2.28       40.67 ± 3.45 
3  39.50 ± 0.79  38.40 ± 1.02  39.20 ± 0.40       38.20 ± 1.69 
4  39.00 ± 1.23  37.70 ± 1.57  38.53 ± 1.46       39.20 ± 2.59 
5  40.27 ± 0.75  37.90 ± 2.36  40.50 ± 1.78       39.20 ± 2.80 
Haemoglobin concentration (g/dl) 
0    10.51 ± 0.647  10.84 ± 1.36  11.12 ± 0.81       11.54 ± 0.32 
1       10.07 ± 1.13  10.04 ± 0.60  10.54 ± 0.27  9.57 ± 0.84 
2   9.30 ± 1.41    9.63 ± 0.43    9.19 ± 0.64  9.81 ± 0.56 
3   9.90 ± 0.51      8.53 ± 0.62*      7.87 ± 0.38*    8.04 ± 0.67* 
4   9.50 ± 0.70    8.41 ± 0.47    9.47 ± 0.88  8.95 ± 0.73 
5   9.17 ± 0.56    8.55 ± 0.30    8.91 ± 0.93  8.89 ± 0.46 
MCV (fl) 
0     104.65 ± 15.76    91.32 ± 17.80  111.12 ± 32.19   93.80 ± 10.11 
1       77.76 ± 3.01  100.18 ± 9.06*    91.48 ± 5.94*   82.35 ± 12.16 
2   78.98 ± 12.78    80.97 ± 10.48  107.63 ± 3.37*   105.03 ± 21.75* 
3       95.04 ± 3.72  85.42 ± 3.47  94.28 ± 2.59       86.08 ± 8.06 
4   76.82 ± 13.16    80.54 ± 6.57*     100.56 ± 12.10*   84.46 ± 8.50* 
5   82.26 ± 14.22        80.06 ± 5.40  81.53 ± 1.96  71.80 ± 15.82 
MCH (pg) 
0  26.73 ± 5.14  22.60 ± 4.49    29.87 ± 11.48       21.60 ± 2.10 
1  22.06 ± 1.87    24.53 ± 2.13*    24.65 ± 2.03*       19.95 ± 3.86 
2  20.37 ± 4.23  19.14 ± 2.74  21.68 ± 2.88       21.83 ± 5.17 
3  23.80 ± 0.81    19.49 ± 2.76*  20.32 ± 3.34   18.18 ± 2.63* 
4  18.82 ± 4.07  17.90 ± 0.53     24.82 ± 4.43*       19.46 ± 2.86 
5  18.88 ± 4.33  18.06 ± 0.74  17.93 ± 1.52       16.30 ± 3.62 
MCHC (g/dl) 
0       25.44 ± 2.02  24.28 ± 6.13  26.32 ± 2.29       23.14 ± 1.82 
1       28.40 ± 2.35    24.52 ± 1.06*  26.96 ± 1.65       24.26 ± 2.70* 
2       21.68 ± 2.90   25.12 ± 2.35*        21.38 ± 1.50   24.18 ± 1.25* 
3       25.10 ± 1.42        22.99 ± 2.67     20.08 ± 0.77*   21.04 ± 1.62* 
4       24.36 ± 1.90        22.38 ± 1.89  24.64 ± 2.76       22.92 ± 1.29 
5       22.78 ± 1.55        22.60 ± 1.30  22.00 ± 2.08       22.73 ± 0.59 
The values bearing asterisk indicate significant (P<0.05) difference compared to those of control group.   
 
The toxicity of any compound depends on many 
factors, such as the chemical and physical form of the 
compound, route of administration, dose and duration 
of exposure, time elapsed after exposure, dietary level 
of the interacting elements, physiological conditions 
(pregnancy, lactation etc.), nutritional status, age and 
sex of the exposed individuals (Haratym-Maj, 2002; 
Khan et al., 2009; Aslam et al., 2009). Although 
pyrethroid effect in both sexes of rabbits in any single 
study have not been investigated previously, but two 
separate studies undertaken at our department in rabbits 
are noteworthy. Basir (2005) reported increased TEC 
and Hb concentration in female rabbits treated with 
lambda cyhalothrin (a pyrethroid) at 1.0, 4.0 and 8.0 
mg.kg
-1 b. wt intraperitoneally but Shah et al. (2007) 
reported anemia in female rabbits treated with CY (25, 
50 and 75 mg.kg
-1 b. wt., intraperitoneally). The above 
workers used lower dose levels of pyrethroids thanPakistan Vet. J., 2009, 29(4): 191-195. 
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Table 2: Haemogram of female rabbits treated at various intervals with cypermethrin 
Groups (Cypermethrin doses; mg.kg
-1 b. wt.)  Parameters/ 
experimental weeks  A (0)  B (50)  C (100)  D (150) 
Total erythrocyte counts (10
6.mm
-3) 
0    4.02 ± 0.25    4.18 ± 0.41    4.11 ± 0.13    4.15 ± 0.24 
1    3.97 ± 0.49    4.10 ± 0.43     4.47 ± 0.49    4.05 ± 0.80 
2    4.46 ± 0.23    4.50 ± 0.33     4.75 ± 0.77    4.80 ± 0.73 
3    4.97 ± 0.75    4.83 ± 0.42     4.13 ± 0.42    5.27 ± 0.50 
4    4.58 ± 0.16    4.68 ± 0.19     4.58 ± 1.14    4.78 ± 1.18 
5    4.80 ± 0.34    4.67 ± 1.06     3.90 ± 0.20    3.63 ± 0.35 
Packed cell volume (%) 
0  38.00 ± 2.36  39.17 ± 2.14  41.33 ± 3.78  40.00 ± 1.41 
1  39.00 ± 2.19  37.33 ± 3.98  40.33 ± 3.27  40.83 ± 1.47 
2  36.80 ± 1.10  37.17 ± 1.33  38.50 ± 2.59  39.17 ± 1.47 
3  37.33 ± 2.07  38.50 ± 3.56  36.67 ± 2.88  39.67 ± 2.80 
4  38.33 ± 1.53  36.00 ± 0.00  37.33 ± 3.51  37.00 ± 4.00 
5  38.00 ± 3.00  35.67 ± 1.16  36.00 ± 3.60  38.33 ± 1.53 
Haemoglobin concentration (g/dl) 
0    8.10 ± 0.67    8.85 ± 0.43    8.96 ± 0.73    9.14 ± 0.95 
1    8.64 ± 0.98    8.43 ± 0.51    8.40 ± 0.52    7.89 ± 0.76 
2    8.12 ± 0.48      9.54 ± 1.13*    10.14 ± 0.48*    8.96 ± 0.54 
3    8.04 ± 0.62    8.17 ± 0.45    8.14 ± 1.52    7.66 ± 0.57 
4    7.92 ± 0.29    7.15 ± 0.24    7.22 ± 0.36    7.30 ± 0.90 
5    8.11 ± 0.54    7.55 ± 0.25  7.61 ± 38    7.71 ± 0.95 
MCV (fl) 
0  94.68 ± 4.29            94.30 ± 9.47      100.29 ± 6.62   96.65 ± 6.47 
1    99.34 ± 10.63     92.16 ± 16.20        90.96 ± 9.91   104.14 ± 20.35 
2  82.65 ± 3.89            82.79 ± 3.29     82.84 ± 15.08     83.00 ± 11.26 
3    81.50 ± 5.17     82.30 ± 7.39     82.50 ± 12.52     86.43 ± 18.09 
4  71.52 ± 2.15            73.80 ± 6.04   86.73 ± 2.15     70.71 ± 14.28 
5    85.87 ± 9.66     79.37 ± 19.88   92.26 ± 6.78    106.42 ± 14.38 
MCH (pg) 
0  20.18 ± 1.72            21.35 ± 2.63  21.75 ± 1.51    21.98 ± 1.09 
1  21.88 ± 2.17            20.68 ± 1.49  18.95 ± 1.69    20.09 ± 4.36 
2  18.13 ± 1.13    2.24 ± 2.44  21.81 ± 3.67    19.75 ± 3.16 
3  17.54 ± 1.16            17.46 ± 0.87  18.46 ± 4.74    17.05 ± 5.15 
4  14.78 ± 0.45            14.69 ± 1.69  16.80 ± 0.35    13.97 ± 3.02 
5  16.95 ± 1.72            16.65 ± 3.14  19.53 ± 1.02    21.51 ± 4.66 
MCHC (g/dl) 
0  21.30 ± 1.07            22.64 ± 1.47  21.73 ± 1.64    22.87 ± 2.55 
1  22.16 ± 2.48            22.77 ± 2.41  20.88 ± 0.94     19.30 ± 1.50* 
2  21.94 ± 1.07     25.65 ± 2.74*     26.38 ± 1.20*    22.89 ± 1.39 
3  21.65 ± 2.67            21.39 ± 2.39  22.19 ± 3.80    19.45 ± 2.50 
4  20.67 ± 0.13            19.87 ± 0.65  19.38 ± 0.86    19.72 ± 0.29 
5  21.38 ± 1.54            21.20 ± 1.32  21.21 ± 1.07    20.06 ± 1.69 
The values bearing asterisk indicate significant (P<0.05) difference compared to those of control group. 
 
those of our study. They, however, used commercial 
mixtures, so that the possibility of interference of other 
compounds (e.g. xylene) cannot be excluded. The 
present study was designed to use 92% CY in inert 
solvent (mustard oil). Thus, in this study anaemia was 
not observed in female rabbits, while anaemia was 
reported by Shah et al. (2007) even at doses lower than 
the present study.  
From the results of this study it was concluded that 
anaemia (macrocytic hypochromic) was induced in the 
male rabbits due to CY treatment at all dose levels, but 
not in the females at the dose levels administered 
during the study. So, sex is also an important factor for 
the anaemia development due to CY toxicity in addition 
to dose administered and duration of the treatment. 
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